Want to see MED full AI Analyst Report?
MED Stock Chart & Stats
$12.16
$0.23(2.38%)
At close: 4:00 PM EDT
$12.16
$0.23(2.38%)
Day’s Range― - ―
52-Week Range$9.22 - $13.45
Previous Close$9.91
Volume152.25K
Average Volume (3M)111.38K
Market Cap
$134.84M
Enterprise Value-$24.06M
Total Cash (Recent Filing)$169.82M
Total Debt (Recent Filing)$27.62M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Oct 26, 2026EPS Estimate
-0.35Next Dividend Ex-DateN/A
Dividend Yield8.2%
Share Statistics
EPS (TTM)-2.33
Shares Outstanding11,180,703
10 Day Avg. Volume105,322
30 Day Avg. Volume111,381
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.30
P/FCF Ratio93.90
Enterprise Value/Market Cap-0.18
Enterprise Value/Revenue-0.08
Enterprise Value/Gross Profit-0.11
Enterprise Value/Ebitda192.49
Forecast
1Y Price Target
$12.00Price Target Upside-1.32% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.15
Revenue Forecast (FY)$287.70M
Bulls Say, Bears Say
Bulls Say
Strong Liquidity And Low LeverageThe substantial cash position and absence of debt provide financial flexibility while the business restructures. This liquidity can support product development, brand investment, and cost initiatives, while reducing financing pressure during the period of weaker operating performance.
Improving Coach Productivity And Cost DisciplineHigher revenue generated per active coach indicates that remaining representatives may be becoming more productive despite a smaller network. Combined with lower SG&A, this supports operating leverage and gives management a clearer path to improve profitability if customer volume stabilizes.
Strategic Metabolic-health RepositioningThe Trilivy repositioning broadens the company beyond a traditional weight-loss message toward metabolic health, while new products and an in-house institute aim to strengthen differentiation. A more science-led platform could improve relevance, credibility, and customer retention over time.
Bears Say
Severe Revenue And Coach-base ContractionThe sharp decline in revenue and active coaches weakens the distribution engine on which Medifast depends. A smaller coach network can reduce customer acquisition and support capacity, making recovery dependent on productivity gains offsetting continued network attrition.
Losses And Operating-margin DeteriorationOperating and net losses show that current sales volumes are insufficient to absorb the company’s cost base, despite still-high gross margins. Continued losses could constrain reinvestment and make the profitability recovery dependent on successful cost reductions and renewed demand.
Weakened Cash Generation And Cost AbsorptionPositive cash flow in a loss period is supportive, but its reduced scale signals weaker cash conversion and diminished financial self-funding capacity. If revenue remains depressed, fixed-cost deleverage and ongoing strategic investment could continue to pressure internally generated cash.
Medifast News
MED FAQ
What was Medifast Inc’s price range in the past 12 months?
Medifast Inc lowest stock price was $9.22 and its highest was $13.45 in the past 12 months.
What is Medifast Inc’s market cap?
Medifast Inc’s market cap is $134.84M.
When is Medifast Inc’s upcoming earnings report date?
Medifast Inc’s upcoming earnings report date is Oct 26, 2026 which is in 3 days.
How were Medifast Inc’s earnings last quarter?
Medifast Inc released its earnings results on Aug 03, 2026. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.65 by $0.37.
Is Medifast Inc overvalued?
According to Wall Street analysts Medifast Inc’s price is currently Overvalued.
Does Medifast Inc pay dividends?
Medifast Inc pays a Quarterly dividend of $1.65 which represents an annual dividend yield of 8.2%. See more information on Medifast Inc dividends here
What is Medifast Inc’s EPS estimate?
Medifast Inc’s EPS estimate is -0.35.
How many shares outstanding does Medifast Inc have?
Medifast Inc has 11,180,703 shares outstanding.
What happened to Medifast Inc’s price movement after its last earnings report?
Medifast Inc reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.65. Following the earnings report the stock price went up 34.292%.
Which hedge fund is a major shareholder of Medifast Inc?
Currently, no hedge funds are holding shares in MED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medifast Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.00 (-1.32% Downside)
$12.00 (-1.32% Downside)
Blogger Sentiment
Bullish
MED Sentiment 100%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Decreased
By 294.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.98%
12-Months-Change
Fundamentals
Return on Equity
-12.68%
Trailing 12-Months
Asset Growth
-3.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Medifast Inc
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
MED Company Deck
MED Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: materially negative near-term operating and top-line trends (notably a 27.6% revenue decline and a 48.7% drop in active coaches) contrast with strong strategic initiatives, improving coach productivity (+41% YoY), a healthy balance sheet ($169.8M cash, no debt), and targeted cost actions (Catalyst) with a goal to return to profitability in Q4 2026. Management emphasized structural steps (new Trilivy brand, scientific institute, compensation changes and training) that could drive medium-term recovery, but sizable current financial pressures and near-term uncertainty remain.View all MED earnings summariesMED Stock 12 Month Forecast
Average Price Target
$12.00
▼(-1.32% Downside)
Technical Analysis
Ownership Overview
5.17% Insiders
14.51% Mutual Funds
0.50% Other Institutional Investors
65.64% Public Companies and
Individual Investors